$Mind Medicine (MNMD.US)$ MindMed被英国创新许可和获取途径(ILAP)指导组颁发创新通行证,用于MM120口服崩解片(ODT)治疗广泛性焦虑障碍(GAD) Mind Medicine (MindMed)(纳斯达克:MNMD)一家处于临床阶段的生物制药公司宣布,其MM120口服崩解片(ODT)已获得英国药物和医疗保健产品监管局(MHRA)颁发的创新护照(Innovation Passport)...
$Mind Medicine (MNMD.US)$ 36美元的目标?!? https://www.moomoo.com/资讯/发帖/41181597?futusource=资讯股票股票页新闻&ns_stock_id=37125992&report_id=37125992&report_type=stock&src=2&main_broker=WzEwMDdd&client_hour_clock=24&us_cid=73925127&channel=4&skintype=3&level=1&全球content=%7B%22promote_content%22%3A%22mm%3Apost%3A41181597%22%2C%22invite%22%3A73925127%7D&data_ticket=d852726825d53ffa91432d8eef415178
Mind Medicine股票讨论
MindMed被英国创新许可和获取途径(ILAP)指导组颁发创新通行证,用于MM120口服崩解片(ODT)治疗广泛性焦虑障碍(GAD)
Mind Medicine (MindMed)(纳斯达克:MNMD)一家处于临床阶段的生物制药公司宣布,其MM120口服崩解片(ODT)已获得英国药物和医疗保健产品监管局(MHRA)颁发的创新护照(Innovation Passport)...
Mind Medicine(MindMed)公司宣布拟议的公开发行
$Mind Medicine (MNMD.US)$
$36的目标!!!!!
https://www.moomoo.com/资讯/发帖/41181597/roth-mkm启动MindMedicine-MNMDUS,评级买入,宣布?futusource=news_stock_stockpagenews&ns_stock_id=37125992&report_id=37125992&report_type=stock&src=2&main_broker=WzEwMDdd&client_hour_clock=24&us_cid=73925127&channel=4&skintype=3&level=2&global_content={%22promote_content%22:%22mm:post:41181597%22,%22invite%22:73925127}&data_ticket=1721821266767476
36美元的目标?!?
https://www.moomoo.com/资讯/发帖/41181597?futusource=资讯股票股票页新闻&ns_stock_id=37125992&report_id=37125992&report_type=stock&src=2&main_broker=WzEwMDdd&client_hour_clock=24&us_cid=73925127&channel=4&skintype=3&level=1&全球content=%7B%22promote_content%22%3A%22mm%3Apost%3A41181597%22%2C%22invite%22%3A73925127%7D&data_ticket=d852726825d53ffa91432d8eef415178
然而,一个小头寸,在逐笔明细中根本没有显示!
https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs
暂无评论